Soluble Fgl2 restricts autoimmune hepatitis progression via suppressing Tc17 and conventional CD8+ T cell function

Baseline IL-2 and the AIH score can predict the response to standard therapy in paediatric autoimmune hepatitis

(2018) Jana Diestelhorst et al.   Scientific Reports

Serum Cytokine Levels and Their Relation to Clinical Features in Patients with Autoimmune Liver Diseases

(2017) Dilyara Akberova et al.   Journal of Immunology Research

Rituximab for the Treatment of Patients with Autoimmune Hepatitis Who are Refractory or Intolerant to Standard Therapy

(2016) Kelly W Burak et al.   CANADIAN JOURNAL OF GASTROENTEROLOGY

Macrophage autophagy protects against liver fibrosis in mice

(2015) Jasper Lodder et al.   Autophagy

In autoimmune hepatitis type 1 or the autoimmune hepatitis-sclerosing cholangitis variant defective regulatory T-cell responsiveness to IL-2 results in low IL-10 production and impaired suppression

(2015) Rodrigo Liberal et al.   HEPATOLOGY

Depletion of B cells induces remission of autoimmune hepatitis in mice through reduced antigen presentation and help to T cells

(2015) Kathie Béland et al.   HEPATOLOGY

Treg Cells Expressing the Coinhibitory Molecule TIGIT Selectively Inhibit Proinflammatory Th1 and Th17 Cell Responses

(2014) Nicole Joller et al.   IMMUNITY

Intrahepatic regulatory T cells in autoimmune hepatitis are associated with treatment response and depleted with current therapies

(2014) Richard Taubert et al.   JOURNAL OF HEPATOLOGY

Increase in TGF-β Secreting CD4+CD25+ FOXP3+ T Regulatory Cells in Anergic Lepromatous Leprosy Patients

(2014) Chaman Saini et al.   PLoS Neglected Tropical Diseases

Dysfunctional CD39POSregulatory T cells and aberrant control of T-helper type 17 cells in autoimmune hepatitis

(2013) Charlotte R. Grant et al.   HEPATOLOGY

Interferon-dependent IL-10 production by Tregs limits tumor Th17 inflammation

(2013) C. Andrew Stewart et al.   JOURNAL OF CLINICAL INVESTIGATION

Characterization of fibrinogen-like protein 2 (FGL2): Monomeric FGL2 has enhanced immunosuppressive activity in comparison to oligomeric FGL2

(2012) Hao Liu et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

IL-17A secretion by CD8+ T cells supports Th17-mediated autoimmune encephalomyelitis

(2012) Magdalena Huber et al.   JOURNAL OF CLINICAL INVESTIGATION

FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency

(2012) Moritz Peiseler et al.   JOURNAL OF HEPATOLOGY

Tc17 CD8+ T Cells Potentiate Th1-Mediated Autoimmune Diabetes in a Mouse Model

(2012) A. Saxena et al.   JOURNAL OF IMMUNOLOGY

British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis

(2011) D. Gleeson et al.   GUT

Cytokine profiles affecting the pathogenesis of autoimmune hepatitis in Japanese patients

(2011) Atsushi Kamijo et al.   HEPATOLOGY RESEARCH

Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State

(2010) f. M. Fisher et al.   DIABETES

Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management

(2010) Ye H. Oo et al.   Hepatology International

A Th17-like developmental process leads to CD8+Tc17 cells with reduced cytotoxic activity

(2009) Magdalena Huber et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Natural and Adaptive Foxp3+ Regulatory T Cells: More of the Same or a Division of Labor?

(2009) Maria A. Curotto de Lafaille et al.   IMMUNITY

The FGL2-FcγRIIB pathway: A novel mechanism leading to immunosuppression

(2008) Hao Liu et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

The novel CD4+CD25+ regulatory T cell effector molecule fibrinogen-like protein 2 contributes to the outcome of murine fulminant viral hepatitis

(2008) Itay Shalev et al.   HEPATOLOGY